Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DDB1 | Q16531 | 1/20 | 0.43 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.43 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.38 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.38 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.38 |
| ▸ | PTGER4 | P35408 | 2/20 | 0.38 |
| ▸ | GRM5 | P41594 | 6/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | ELANE | P08246 | 2/20 | 0.36 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17424676 | 1.00 | DDB1 (0.43) | DDB1CRBNPDE4BPDE4DCLK4 | |
| SCHEMBL21453906 | 0.96 | DDB1 (0.41) | DDB1CRBNPDE4BPDE4DCLK4 | |
| SCHEMBL21453252 | 0.95 | DDB1 (0.40) | DDB1CRBNPDE4BPDE4DCLK4 | |
| SCHEMBL21397118 | 0.95 | DDB1 (0.40) | DDB1CRBNPDE4BPDE4DCLK4 | |
| SCHEMBL23816693 | 0.94 | DDB1 (0.45) | DDB1CRBNPDE4BPDE4DCLK4 | |
| SCHEMBL17721903 | 0.92 | DDB1 (0.41) | DDB1CRBNCLK4PTGER4GRM5 | |
| SCHEMBL17721906 | 0.92 | DDB1 (0.41) | DDB1CRBNCLK4PTGER4GRM5 | |
| SCHEMBL21453869 | 0.92 | ALDH1A1 (0.38) | DDB1CRBNPDE4BPDE4DCLK4 | |
| SCHEMBL21453258 | 0.91 | DDB1 (0.38) | DDB1CRBNPDE4BPDE4DCLK4 | |
| SCHEMBL21453256 | 0.91 | DDB1 (0.39) | DDB1CRBNPDE4BPDE4DCLK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11469381-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2022-10-11 | — | — | US | disclosed |
| US-20190312209-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-10-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11469381-B2 | Condensed cyclic compound and organic light-emitting device including the same | ARL1, CCNL2, CRY1 | DDB1 1386/4885CRBN 817/4885PDE4B 4424/4885 |
| US-20190312209-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | ARL1, CCNL2, CRY1 | DDB1 1386/4885CRBN 817/4885PDE4B 4424/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.